Clinical Trial Update: Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating a combination of low-dose radiation, SBRT, tislelizumab, and platinum-based chemotherapy for stage IIA to IIIB non-small …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Platinum-based chemotherapy (platinum-based chemotherapy)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Sichuan University | Conditions: Lung Cancer, Non-small Cell Lung Cancer | Phase 2 | Status: RECRUITING